Screener
Trevi Therapeutics, Inc. TRVI Compensation and benefits
Compensation and benefits at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The source filing: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206390
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Operating activities: | ||
| Net loss | $(13,192) | $(10,340) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Stock-based compensation | 2,191 | 1,208 |
| Operating lease right-of-use assets | 105 | 112 |
| Depreciation and amortization | 34 | 37 |
| Accretion of available-for-sale marketable securities, net | (431) | (395) |
| Changes in operating assets and liabilities: |
Item 1. Condensed Consolidated Financial Statements.
FAQ
- What is Trevi Therapeutics, Inc.'s compensation and benefits?
- Trevi Therapeutics, Inc. (TRVI) reported compensation and benefits of $2.19M in Q1 2026.
- How has Trevi Therapeutics, Inc.'s compensation and benefits changed year-over-year?
- Trevi Therapeutics, Inc.'s compensation and benefits increased by 81.4% year-over-year, from $1.21M to $2.19M.
- What is the long-term trend for Trevi Therapeutics, Inc.'s compensation and benefits?
- Over 4 years (2021 to 2025), Trevi Therapeutics, Inc.'s compensation and benefits has grown at a 19.5% compound annual growth rate (CAGR), from $2.54M to $5.19M.
- What does compensation and benefits mean?
- Total employee-related costs including salaries, wages, bonuses, commissions, stock-based compensation, health insurance, retirement contributions, and payroll taxes.
Ask your AI about Trevi Therapeutics, Inc.'s compensation and benefits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude